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Coincubations of radiolabeled leukotriene B, (LTB,) and ethanol with isolated rat hepato- 
cytes led to formation of one dihydroxylated and two novel Poxidized metabolites of LTB,. 
The major radioactive peaks from reverse-phase-high performance liquid chromatography 
(RF-HPLC) eluted with material absorbing UV light maximally at 270 nm, with shoulders at 
260 and 280 nm, indicating retention of the conjugated triene structure of the parent molecule 
in each metabolite structure. Following purification, catalytic reduction, and derivatization, 
mass spectrometric analysis revealed that all three metabolites were hydroxylated at the C-3 
carbon atom based on characteristic ions at m/z 201 and 175 in the electron ionization mass 
spectra of the metabolites. Negative-ion electron capture mass spectrometry of the metabo- 
lites as pentafluorobenzyl (PFB) ester, trimethylsilyl ether derivatives aided structural char- 
acterizations while revealing interesting fragmentations. A ketene-containing ion appeared to 
result from the loss of both PFB groups (one as I’FB alcohol), while a lactone alkoxide ion 
appeared to result following loss of PFB and bisftrimethylsilyl) ether. From these data three 
novel LTB, metabolites were suggested to be 3,20-dihydroxy-LTB, (3,20-diOH-LTB,), 3-hy- 
droxy-LB-carboxy-LTB, (3-OH-LB-COOH-LTB,), and 3-hydroxy-16_carboxy-LTB, (3-OH-16- 
COOH-LTB,). The significance of the almost exclusive formation of these 3-hydroxylated 
LTB, metabolites in the presence of ethanol is currently unknown, but may result from 
interrupted p-oxidation from the C-l carboxyl moiety. (1 Am Sot Mass Spectrom 1992, 3, 
762-768) 
L eukotriene B, (LTB,, 5(S),12(R)-dihydroxy- 6Z,BE,lOE,14Z-eicosatetraenoic acid) is a lipid mediator enzymatically derived from arachi- 
donic acid [l, z]. Several investigators have demon- 
strated numerous biological activities of this endoge- 
nous substance which supports its putative role in 
inflammation and several pathophysiological condi- 
tions such as arthritis and psoriasis [3]. This potent 
substance is extensively metabolized in vivo [4] and 
several metabolic studies have utilized isolated cells 
or tissues as model systems for studying LTB, 
metabolism 15-91. LTB, is o-oxidized in both 
neutrophils and hepatocytes to 20-OH-LTB, (5,12,20- 
trihydroxy-6,8,10,14eicosatetraenoic acid) and 20- 
COOH-LTB, (5,12-dihydroxy-6,8,10,14-eicosatetraen- 
1,20-dioic acid) [559]. Unlike neutrophils, which utilize 
a specific cytochrome P-450 [lo, 111 or aldehyde dehy- 
drogenase [121, hepatocytes appear mainly to catalyze 
this oxidation with alcohol dehydrogenase and alde- 
hyde dehydrogenase [13, 141. Effects of ethanol (a 
favored substrate for alcohol dehydrogenase) on hepa- 
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tocyte metabolism of LTB, in other laboratories have 
raised questions about the possible effects of ethanol 
on the production of LTB, metabolites recently charac- 
terized in our laboratory 1151. 
Early studies of LTB, metabolism in isolated rat 
hepatocytes revealed moxidation to ZO-OH and ZO- 
COOH-LTB, followed by P-oxidation to lS_COOH- 
LTB, (5,12-dihydroxy-6,8,10,14-octadecatetraen-1,18- 
dioic acid) [7]. Further P-oxidative chain-shortening 
and amino acid conjugation resulted in 16COOH-LTB, 
(5,12-dihydroxy-6,8,10-hexadecatrien-1,16-dioic acid) 
and 18-tauro-LTB,, respectively, as previously re- 
ported 1151. Interestingly, production of these ,8 
oxidized metabolites was minimal when 44 mM 
ethanol was present in the incubation mixture. Instead, 
other LTB,-related, radioactive, UV-absorbing chro- 
matographic peaks appeared, representing different 
metabolites based on different high performance liquid 
chromatography (HPLC) retention times. In contrast to 
previous studies which showed substantial inhibition 
of hepatocytc LTB, metabolism by ethanol [la], this 
study revealed extensive metabolism to previously 
unidentified metabolites. 
The purpose of this study was to structurally char- 
acterize ethanol-dependent LTB, metabolites by using 
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mass spectrometry. Analyses of both positive and neg- 
ative ions were complementary for structure elucida- 
tion purposes, and several characteristic ions were 
identified from these hydroxylated carboxylic acids. 
Experimental 
Materials. LTB, was kindly provided by Dr. Robert 
Zipkin (Biomol Research Labs, Plymouth, PA) and 
(5,6,8,9,11,12,14,15-[ “HI,)-LTB,, 150-200 Ci/mmole 
was purchased from DuPont-New England Nuclear. 
Reverse-phase-HPLC (RI-HPLC) columns (150 x 
4.6 mm Apex II ODS) were from Jones Chromatogra- 
phy (Columbus, OH). HPLC solvents were from Fisher 
Chemical Company (Fairlawn, NJ). Octadecysilyl 
CODS) SepI’ak cartridges were from Waters Associates 
(Milford, MA). Bis(trimethylsilyl)trifluoroacetamide 
(BSTFA) was obtained from Supelco (Bellefonte, PA). 
Diazald, used to prepare ethereal solutions of dia- 
zomethane, was obtained from Aldrich Chemical Co. 
(Milwaukee, WI). 
Methods. Hepatocytes were isolated by the collage- 
nase method of Berry and Friend [I61 with slight 
modifications. Male and female Sprague-Dawley rats 
(200-500 g) were anesthetized with pentobarbital 
(65 mg/kg). After opening the abdomen to expose the 
portal vein, the liver was perfused with Ca”-free 
buffer (37”C, oxygenated) and removed from the ani- 
mal. The liver was then perfused with 35 u/ml colla- 
genase (Type II, Worthington, Freehold, NJ) and 1 mM 
Ca2+-containing oxygenated buffer for 15 min. After a 
5 min washout with collagenase/Ca2+-free buffer, 
hepatocytes were freed from the liver and purified by 
four steps of differential centrifugation using a sepa- 
rate wash buffer each time. The hepatocytes were 
resuspended in an incubation buffer containing 129 
mM NaCl, 5.2 mM KCl, 3 mM NazHPO,, 0.9 mM 
MgSO,, 1.1 mM CaCl,, 4 mM glucose, 10 r&I trisfhy- 
droxymethyl)aminomethane, equilibrated with 95% 
O/5% CO,, pH 7.4. Cell viabilities were > 85% as 
determined by trypan blue exclusion. 
Hepatocyte incubations were carried out with 
12 FM LTB,, 3.5 PCi [ 3H,]LTB,, 1.25 X 10’ hepato 
cytes/25 ml, 44 mM ethanol (0.2% w/v) for 30-60 
min. The LTB, and ethanol were added simultane- 
ously, premixed in incubation buffer. Flasks were filled 
with 95% 0,/5% CO, and then sealed for the dura- 
tion of the incubations. Incubations were terminated 
by the addition of 4 vol of cold ethanol ( - 20 ‘Cl. After 
2 h at - 7O”C, the ethanolic suspension was cen- 
trifuged to pellet cell debris and precipitated proteins. 
The supematant was dried under vacuum and the 
residue dissolved in water. Following acidification with 
acetic acid, an aliquot was injected onto an RF-HPLC 
column and monitored for UV absorbance and ra- 
dioactivity in tandem (HP-1040A photodiode array 
detector, Hewlett-Packard, Palo Alto, CA; Flow 
One/Beta, Radiomatic, Tampa, FL). The remainder of 
the material was then subjected to solid-phase extrac- 
tion utilizing a 5-ml 0.1% acetic acid wash followed by 
methanol elution of lipophilic LTB, metabolites. This 
methanol fraction was dried under vacuum and sepa- 
rated by RP-HPLC. The first stage of RP-HPLC (sys- 
tem 1) utilized a linear gradient from 50% solvent A 
(16.6 mh4 ammonium formate adjusted to pH 4.5 with 
HCl) to 100% solvent B (methanol/solvent A/acetic 
acid, 90 : 10 : 0.1) in 30 min at a flow rate of 1 ml/min. 
LTB, metabolites were collected manually based on 
their UV absorbance and rechromatographed individu- 
ally by using a linear gradient from 100% Hz0 to 50% 
acetonitrile in 50 min at 1 ml/mm (system 2). Metabo- 
lites were again collected manually and UV spec 
troscopy was performed on purified metabolites by 
using an HP-8452A W spectrophotometer (Hewlett 
Packard). 
Metabolites derivatized for electron ionization (EI) 
(70 eV) were methylated with ethereal diazomethane 
for 5 rnin in methanol, dried under a stream of nitro- 
gen, and purified as methyl esters by using HPLC 
system 2. The purified methyl esters were then reduced 
by catalytic hydrogenation with platinum oxide and 
hydrogen gas for 90 s at - 20 “C. The reduced methyl 
esters were then reacted with 100 ~1 of 50% BSTFA in 
acetonitrile for 20 min at 60 “C. EIectron ionization gas 
chromatography-mass spectrometry (CC-MS) was car- 
ried out on a Finnigan SSQ-70B mass spectrometer 
(Finnigan Mat, San Jose, CA) interfaced with a DB-1 
capillary column (10 m x 0.25 mm inside diameter, 
0.2 pm film thickness programmed from 100 to 320 “C 
at 15 “C/min using helium as carrier gas. Metabolites 
derivatized for negative ion electron capture ionization 
(ECI) mass spechometry were dissolved in 30 ~1 
methanol to which 70 pl acetone was added, followed 
by 20 ~1 pentafluorobenzylbromide (Aldrich) and 10 
~1 N,N-diisopropylethylamine (Aldrich). The mixtures 
were heated to 60°C for 15 min, dried under vacuum, 
dissolved in 50 ~1 MeOH, and the derivatives were 
purified as their W-absorbing, pentafluorobenzyl 
esters by using HPLC system 2. The purified benzyl 
esters were then treated with BSTFA as described 
above for the methyl ester, trimethylsilyl ether deriva- 
tives. Negative ion GC-MS analyses were performed 
on a Finnigan SSQ-70B using methane as moderating 
gas at 0.3 torr source pressure. CC conditions were 
identical to those described above. 
Results 
After LTB, was incubated with rat hepatocytes for 
periods up to 1 h in the presence of 44 mM ethanol, no 
LTB, or 3-OH-LTB, remained, in contrast to the result 
when shorter incubation times were employed, as pre- 
viously reported [17]. The coelution of radioactive and 
UV-absorbing LTB, metabolites is illustrated in Figure 
1. Three major peaks, designated H,, H,, and H,, are 
indicated along with their UV absorbance spectra in 
the insets to this figure. The retention time of 3-OH- 
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LTB, is indicated by the arrow at 28 min. A separate 
experiment with a shorter incubation time (15 min) 
resulted in a major metabolite at this retention time 
(data not shown). LTB, metabolites which normally 
appear in the absence of ethanol were not apparent by 
comparison of HPLC retention times. Each labeled 
metabolite represents a novel substance generated 
when ethanol was present in the incubation; together 
the new metabolites correspond to 24% of the initial 
LTB, added to the hepatocytes. 
The structure of 3-OH-LTB, was determined by 
GC-MS analysis following reduction and derivatiza- 
tion. The EI mass spectrum revealed ions which corre- 
lated with those seen in a previously published mass 
spectrum [7] at m/z 477, 395, 387, 311, 247, 215, 201 
(base peak), 175, and 147. The ECI mass spectrum of 
derivatized 3-OH-LTB, contained a base peak at 
MI/Z 567 (M-181, loss of PFB) and ions at rrf/z 477, 
387, and 297, suggesting losses of up to three TMSOH 
groups from the M-181 ion of this derivative which 
had an equivalent chain length (ECL) of 23.9. The 
presence of three hydroxyl groups on the underiva- 
tized metabolite, molecular weight information indi- 
cating four intact double bonds, the WV absorbance 
spectrum (data not shown), and a similar EI mass 
spectrum and gas chromatographic equivalent chain 
length (ECL) (25.3 versus 25.5) of the reduced metabo- 
lite identified previously (7), are all consistent with 
identification as 3,5,12-trihydroxyeicosatetraenoic acid 
(3-OH-LTB,). The stereochemistry of the 3-hydroxy 
group was not determined. 
Metnbolite H,. The EC1 mass spectrum (Figure 2a) of 
the PFB, trimethylsilyl (TMS) derivative of metabolite 
H, (ECL = 26.5) revealed an M-181 ion at m/z 655 
(base peak). Because this ion appeared 88 u higher 
10 20 
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Figure 1. HPLC chromatograms of LT8, mrtaholites illustrat- 
ing coeluting UV-absorbing and radioactive peaks obtained by 
tandem UV-absorption/scintillation counting. ‘The UV-absorption 
spectra of metabolites H,, H,, and H, are shown in the insets. 
The retention time for the 3-OH-LTD, metabolite is indicated. 
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Figure 2. Mass spectra of metabolite H, under negative- and 
positive-ion conditions. (a) ECl-MS analysis uf H, as the 
PFB,TMS derivative; (b) EI-MS analysis of H, as the reduced. 
methylated, TMS derivatwe. 
than the M-181 ion of derivatized 3-OH-LTB,, this 
suggested that H, contained an additional hydroxyl 
group in the underivatized molecule. Other major ions 
appeared at m/z 565 (M-181-90, loss of PFB and TMS- 
OH) and m/z 475 (M-181-90-90, loss of PFB and 2 
TMSOH groups). 
EIectron ionization mass spectrometric analysis of 
metabolite H, as the methyl ester, TMS derivative 
following catalytic hydrogenation (Figure 2b) revealed 
ions at m/z 663 (M-15, loss of CH,) and other signifi- 
cant ions at m/z 483 (M-15-90-90, loss of CH,, and 
two TMSOH groups), m/z 477 (fragmentation indi- 
cated), and nz/z 387 (47’7901, m/z 303 (fragmentation 
indicated), and m/z 201 (291-90, cleavage as indicated 
followed by loss of TMSOH). The ECL of this deriva- 
tive of metabolite H, was determined to be 28.2. 
Based on the UV absorbance spectrum, the presence of 
an additional hydroxyl group in the underivatized 
metabolite, and the ions appearing in the EI mass 
spectrum corresponding to ions seen previously in the 
El mass spectrum of reduced, derivatized 3-OH-LTB, 
(m/z 477, 201, and 1751, metabolitc H, was assigned 
the structure 3,5,X&20-tetrahydroxycicosatetraenoic 
acid (3,20-dihydroxy-LTB,). 
Metnbalite H,. When metabolite H, was derivatized 
and analyzed by GC-MS under negative ion conditions 
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(Figure 3a), ions appeared at m/z 749 (M-181), m/z 
659 (M-181-90), m/z 587 (M-181-162, loss of TMS-O- 
TMS), and m/z 551 (M-181-198, loss of PFB and PFB- 
OH). The M-181 ion and the presence of M-181-162 
and M-181-198 fragment ions suggested that H, might 
be a dicarboxylic acid metabolite of LTB,. Similar mass 
spectral behavior has been observed for 20-COOH- 
LTB, and 18-COOH-LTB, derivatives [15]. The M-181 
ion was 88 u higher than the corresponding M-181 ion 
appearing in the EC1 mass spectrum of derivatized 
18-COOH-LTB, (data not shown), suggesting the pres- 
ence of an additional hydroxyl group in the underiva- 
tized molecule. The PFB, TMS derivative of metabolite 
Hj had an ECL of 29.4 
Analysis of reduced, derivatized metabolite H, by 
EI GC-MS (Figure 3b) revealed several ions identical to 
those seen in the analogous analysis of metabolites H, 
and 3-OH-LTB, (m/z 477,201, and 175), suggesting an 
identical structure from the C-12 to C-l portion of this 
metabolite, in particular the presence of a hydroxyl 
moiety at the C-3 carbon. Because the ion at m/z 231 
was seen during EI mass spectrum of reduced 18- 
COOH-LTB, [7], this suggested that the structure of 
the C-12 to C-18 portion of metabolite H, was identical 
to that of 18-COOH-LTB,. Reduced H,-Me-TMS had 
an ECL of 26.3. From these observations, the M-15 (loss 
of CH,) ion at m/z 591, the negative ion mass spec- 
trum, and the UV absorbance spectrum, it was con- 
m/z 
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Figure 3. GC-MS analysis of mctabolite H, under negative- and 
positive-ion conditions. (a) EC1 mass spectrum of metabolite H, 
as the PFB, TMS derivative; Ib) El mass spectrum of reduced H, 
as the methyl ester, TMS ether derivative. 
eluded that metabolite H, was 3,5,12-trihydroxy- 
octadecatetraene-1,38-dioic acid (3-OH-18-COOH- 
LTB,). 
Metabolite H,. Analysis of the PFB,TMS derivative 
of metabolite H, (ECL = 27.9) by EC1 GC-MS 
(Figure 4a) revealed four major ions (m/z 723, 633, 
561, and 5251, each of which was 26 u less than the 
corresponding ion seen in the EC1 spectrum of deriva- 
tized metabolite H, above. Based on the previous 
study [I51 which showed an analogous difference in 
masses (26 u) between the mass spectra of 18-COOH- 
LTB,PFB-TMS and 16COOH-LTB,PFB-TMS, H, was 
hypothesized to be a eoxidized chain-shortened, re- 
duced metabolite of H,. 
Electron ionization GC-MS analysis of the reduced 
methylated, trimethylsilylated derivative of H ,_ 
(Figure 4b, ECL = 24.6) revealed ions at m/z 547 (M- 
311, m/z 477, and m/z 389 (fragmentations indicated), 
m/z 387 (477-901, m/z 383 (M-15-90-901, m/z 299 
(389-90), m/z 203, and m/z 201 (291-90). Again, the 
presence of an m/z 201 ion suggested an hydroxyl 
moiety on the C-3 carbon of the underivatized metabo- 
lite. The ion at m/z 203 was analogous to the m/z 203 
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Figure 4. CC-MS analysis of metabolite H, under negative- 
and positive-ion conditions. (a) EC1 mass spectrum of mctabo- 
lite H, as the PFB,TMS derivative; (b) El mass spectrum of 
reduced H, as the methyl ester, TMS ether derivative. 
766 SH1RLF.Y AND MURPHY J Am Sot Mass Spectrom 1992,3,762-768 
ion observed during EI analysis of reduced LTB,-Me- 
TMS, except that with the H, derivative, this ion 
originates from the opposite end of the molecule. The 
UV absorbance spectrum and both negative and posi- 
tive ion mass spectra were consistent with identifica- 
tion of metabolite H, as 3,5,12-trihydroxyhexade- 
catriene-1,16-dioic acid (3-OH-16-COOH-LTB,). 
Certain fragment ions appearing in both negative 
and positive ion mass spectra served critical roles in 
the structural characterization of these metabolites. In 
the EC1 spectra of two metabolites, an [M-181-198] 
ion appeared, suggesting that these metabolites had 
common structural features. The [M-181-198]- ions 
could be accounted for if both metabolites were in fact 
dicarboxylic acids. A mechanism for the origin of these 
ions could involve ketene formation remote to the 
ionized carboxylate resulting from the loss of a PFB 
group (Scheme I). Another common ion appeared in 
the EC1 mass spectra at [M-181-162]- for all metabo- 
lites including LTB, itself (data not shown). When 
[2H,8]BSTFA was used for the derivatization, this ion 
was observed to lose two TMS moieties, consistent 
with formation of bis(trimethylsilyl) ether (TMS-O- 
TMS). We suggest that the driving force for this rear- 
rangement is favorable attack of the carboxylate anion 
at C-5 with lactone formation and the anionic charge 
site moved to the oxygen at C-12 (Scheme II). 
Two particular ions in the El mass spectra of 
reduced, methylated, trimethylsilylated LTB, metabo- 
lites served as diagnostic indicators of a 3-hydroxy 
substituent present in the molecules. These ions, 
m/z 201 and 175, were evident in all of the EI mass 
spectra presented, as well as the EI spectrum of reduced 
3-OH-LTB,-Me-TMS published previously 171. The m/z 
201 ion is proposed to originate from a loss of trimeth- 
ylsilylanol from the nz/z 291 fragment ion, as illus- 
trated in Scheme III. The formation of this latter ion in 
LTB, has been studied previously [18]. Though not as 
prevalent, the m/z 175 ion is likely an a-cleavage 
product. 
Discussion 
The relatively low concentrations of ethanol encoun- 
tered in human beings during moderate ingestion of 
alcoholic beverages (lo-50 mM) is known to exert 
profound central nervous system effects. Less well 
understood are the effects of these low concentrations 
of ethanol on biochemical events. Chronic ethanol in- 
LeaOf 
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gestion by humans is known to lead to significant 
impairment of the immune defense system as well as 
tissue injury 1191. For example, chronic alcohol inges- 
tion results in liver damage and alcoholic hepatitis in 
some cases. Alcoholic hepatitis is manifest by infiltra- 
tion of polymorphonuclear leukocytes into the liver 
parenchyma with concomitant damage to hepatocytes 
following activation of the neutrophil[20]. Considering 
the fact that leukotriene B, is known to be a potent 
chemotactic agent which can recruit neurophils into a 
tissue, we have been interested in the effect of ethanol 
on leukotriene B, synthesis and metabolism. 
Ethanol caused a qualitative alteration of the 
metabolite profile resulting from isolated rat hepato- 
cyte preparations exposed to exogenous leukotriene 
B,. The biochemical pathways are summarized in Fig- 
ure 5. Extensive metabolism of LTB, in the presence of 
ethanol resulted in the production of three novel 
metabolites. Previously, LTB, was determined to 
undergo *oxidation and P-oxidation in hepatocytes, 
at least to 16-COOH-LTB, [7, 151. Recent reports re- 
garding the involvement of alcohol dehydrogenase and 
aldehyde dehydrogenase in hepatocyte conversion of 
20-OH-LTB, to 20-COOH-LTB, [13, 141 led to studies 
[17] which were consistent with the findings of Keppler 
and co-workers [14] that ethanol cause a “crossover 
effect” on relative amounts of *oxidized LTB, 
metabolites produced in hepatocytes. In contrast to 
their studies, which included 0.4 mmol/l arachidonate 
and 5 g/l bovine serum albumin in the incubation 
buffer to slow metabolism, our studies displayed more 
extensive metabolism and the production of several 
LTB, metabolites. 
Little is known about the nature of the 3- 
hydroxylation reaction and accumulation of such prod- 
ucts in the presence of ethanol. It likely represents a 
product formed from the first two steps of one round 
of @oxidation from the carboxy terminus of LTB,. 
However, we cannot rule out the possibility that a 
3-hydroxylation reaction might be mediated by an- 
other oxidase such as cytochromc P450. Considering a 
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Figure 5. Summary of metabolic events occurring in isolated rat 
hepatocytes during metabolism of LTB, in the presence of 
ethanol. In the absence of ethanol, alcohol dehydrogenase is the 
primary route of metabolism 2O-OH-LTB, to ZO-COOH-LTB,. 
The step is also catalyzed by cytochrome P450 which can catalyze 
this *oxidation step. Unique metaboIites formed in the presence 
of alcohol have a 3-hydroxy substituent. 
hydroxy group to a 3-0~0 moiety by L3-hydroxyacyl- 
CoA dehydrogenase would require nicotinamide 
adenine dinucleotide (NAD+) as a cofactor, which is in 
short supply when ethanol is present in hepatocyte 
incubations [21]. There are two potential sites for LTB, 
@oxidation within the hepatocyte, the peroxisome, 
and the mitochondria. There are some differences be- 
tween the enzymes involved in p-oxidation, however, 
the overall steps are identical. Recently, it has been 
shown that both mitochondria and peroxisomes partic- 
ipate in hepatic LTB, metabolism [22]. For both sites of 
p-oxidation, LTB, must be converted into the 
coenzyme-A (CoA) thioester. However, for mitochon- 
drial oxidation, formation of an acyl carnitine ester is 
required for transport into the mitochondria. Based 
upon the observed metabolism of 20-CCOH-LTB, by 
both of these organcUes, it would appear that both of 
these required esters can be readily synthesized when 
an ticarboxyl group is present in the LTB, metabolite. 
Formation of LTB,-CoA by rat liver microsomes has 
also been reported [23], but nothing has been reported 
for the formation of the LTB,-carnitine ester. Peroxiso- 
ma1 P-oxidation involves fatty acyl CoA oxidase which 
mediates the first step of @oxidation with the libera- 
tion of H,O, [24]. This H,O, can be used in conjunc- 
tion with catalase to metabolize ethanol to acetalde- 
hyde within the peroxisome [25]. However, further 
oxidation within the peroxisome requires NAD+, the 
lack of which prevents further /3-oxidation. However, 
in the case when an wcarboxy metabolite is formed by 
cytochrome P450-dependent oxidation, uptake into the 
mitochondria can occur. Once in the mitochondria (as 
the 20COOH-CoA ester) P-oxidation might proceed 
because of the ability of the mitochondria to oxidize 
NADH to NAD*. Because the reducing equivalants for 
ethanol metabolism in the cytosol largely come from 
the capacity of the malate-aspartate shuttle in the mito- 
chondria membrane [26], the availability of NAD+ 
within the mitochondria is somewhat reduced and 
overall metabolism by P-oxidation is partially inhib- 
ited. Taken together, these biochemical pathways 
would account for the peroxisomal formation of 3-hy- 
droxy metabolites of LTB, with continued, but reduced, 
Poxidation within the mitochondria of *oxidized 
products formed by cytochrome P450. 
It is not known how the ethanol-dependent forrna- 
tion of 3-hydroxylated metabolites of LTB, relates to 
the recently reported 3-hydroxylated metabolites of 
dodecanoate, cisd-decenoate, and cis-.5-tetradecenoate 
produced from the 10,000 x g fraction from rat liver 
homogenates [27]. However, in incubations with the 
latter substrate, the authors reported that the addition 
of NADC did not appear to affect the extent of 3- 
hydroxylated metabolite accumulation, suggesting that 
3-hydroxylated fatty acid metabolites can accumulate 
even when NADi is not in short supply in the 10,000 
x g pellet model. 
The LTB, metabolite, 3-OH-16COOH-LTB,, proba- 
bly arose from 3-OH-18-COOH-LTB, by chair- 
shortening through P-oxidation with the CoA ester 
located at the C-18 carbon atom, as suggested above 
within the mitochondria. Because aoxidation typically 
results in the loss of two carbons as methylene units, 
this would lead to a loss of 28 u from an homologous 
series of P-oxidize metabolites. However, as shown for 
the P-oxidation of 18-OH-LTB, 1151 and 18-COOH- 
N-acetyl-LTE, [28], only 26 u are lost when an isolated 
double bond is present an even number of carbons 
from the CoA ester moiety. The dicarboxylic acid 
metabolites of LTB, presented above indeed differed 
by only 26 u and formation of the reduced metabolite, 
3-OH-16-COOH-LTB,, strongly argues for the opera- 
tion of 2,4-dienoyl-CoA reductase in the processing of 
the CoA ester of 3-OH-18-COQH-LTB, following oxi- 
dation by acyl-CoA dehydrogenase (mitochondrial 
process) [ 291. 
Conclusion 
The presence of ethanol in rat hepatocyte incubations 
caused an alteration of the normal metabolite profile 
resulting from exogenously administered LTB,. 
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Although ethanol does inhibit LTB, metabolism medi- 
ated by alcohol dehydrogenase [14, 171, we found that 
Poxidation can indeed take place in the presence of 44 
mM ethanol. The duration of incubation and ethanol 
concentration used in this study were chosen to opti- 
mize production of previously unidentified LTB, 
metabolites; but it should be mentioned that these 
metabolites were also observed when lower ethanol 
concentrations were employed in hepatocyte incuba- 
tions. Further investigations of mechanisms of metabo- 
lite formation and possible involvement of these 
metabolites in alcohol-related pathophysiology are cur- 
rently in progress. 
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